← Back to Search

Acupuncture for Lung Cancer (POISE Trial)

Phase 3
Recruiting
Led By Dugald Seely, ND, MSc
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults eligible for complete resection of lung, gastric or esophageal cancer
Be older than 18 years old
Must not have
Any wedge resections of lung cancer
Small cell, carcinoid, or gastrointestinal stromal (GIST) tumours
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial is studying the effect of acupuncture on quality of life for patients with thoracic cancer who are undergoing surgery.

Who is the study for?
This trial is for adults ready to undergo complete removal of lung, gastric, or esophageal cancer. It's not for those who've had minor lung surgery, seen a naturopathic doctor recently, are pregnant/breastfeeding, used experimental drugs lately, have certain tumor types or recent active cancer treatment.Check my eligibility
What is being tested?
The trial tests an integrative approach combining nutrition and physical activity guidance with psychological support and supplements like Green Tea Extract and Vitamin D3. The goal is to improve quality of life after thoracic surgery by reducing complications and the risk of cancer returning.See study design
What are the potential side effects?
Potential side effects from the supplements may include digestive issues, allergic reactions, changes in energy levels or mood disturbances. However, these interventions aim to be gentle and supportive alongside conventional care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My lung, stomach, or esophagus cancer can be completely removed by surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a part of my lung removed due to cancer.
Select...
My cancer is not small cell, carcinoid, or GIST.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cross-over and contamination in the control arm - Mediterranean Diet Scores
Cross-over and contamination in the control arm - Physical Activity levels
Cross-over and contamination in the control arm - Psychological Health Activities
+3 more
Secondary outcome measures
Communication
Inflammatory Response
Natural Killer Cell Function
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Integrative Care (Treatment)Experimental Treatment10 Interventions
Participants in the Integrative arm will receive standard surgical and oncologic care at The Ottawa Hospital plus complementary care guided by a naturopathic doctor at The Centre for Health Innovation
Group II: Standard Care (Control)Active Control1 Intervention
Participants in the control arm will receive standard surgical and oncologic care at The Ottawa Hospital
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Green Tea Extract
2019
N/A
~40

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
565 Previous Clinical Trials
2,786,153 Total Patients Enrolled
The Canadian College of Naturopathic MedicineOTHER
22 Previous Clinical Trials
2,617 Total Patients Enrolled
Lotte & John Hecht Memorial FoundationOTHER
17 Previous Clinical Trials
4,573 Total Patients Enrolled

Media Library

Psychological Recommendations Clinical Trial Eligibility Overview. Trial Name: NCT04871412 — Phase 3
Lung Cancer Research Study Groups: Integrative Care (Treatment), Standard Care (Control)
Lung Cancer Clinical Trial 2023: Psychological Recommendations Highlights & Side Effects. Trial Name: NCT04871412 — Phase 3
Psychological Recommendations 2023 Treatment Timeline for Medical Study. Trial Name: NCT04871412 — Phase 3
~3 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top